rac-(1R,5S,6S)-3-azabicyclo[3.2.0]heptan-6-ol hydrochloride, 95.0%, 250mg

8-Iodoimidazo[1,2-c]pyrimidin-5(6H)-one, 98%, 100mg

6-(BENZYLOXY)-2-METHYLNICOTINIC ACID, 95.0%, 5g

D(+)-Mannose, ≥99.5%, for biochemistry, 50 g, plastic packaging.

Bis((R)-4-methyl-4,5-dihydrooxazol-2-yl)methane, 97%, 1g

2-Methylthiophen-3-amine hydrochloride, 95+%, 10g

Methoxypolyethylene glycols-average M.W. 2000, average M.W. 2000, 250mg

2-(4-Bromomethyl-phenyl)-5-(3-nitro-phenyl)-[1,3,4]thiadiazole, 95.0%, 1g

(R)-2-((tert-Butoxycarbonyl)amino)-2-(2-methoxyphenyl)acetic acid, 95.0%, 250mg

methyl 3-chloro-6-fluoro-1-benzothiophene-2-carboxylate, 95.0%, 5g

(S)-tert-Butyl (1-oxopropan-2-yl)carbamate, 97.0%, 5g

9,10-Di(1H-pyrazol-4-yl)anthracene, 98%, 100mg

IODOCYCLOBUTANE, 95.0%, 1g